Monitor the Nasdaq delisting effective November 18, 2026 and any hearing request, as a five-day suspension triggers a Triggering Event requiring ~$0.3 million maintenance failure payments per 30-day period. Watch for progress on the Opifex transaction, which would be highly dilutive (existing holders ~15%), and the pending Abaca litigation ruling with potential loss up to $7.8 million.
How similar events traded
Executive Summary
SHF Holdings filed an S-1 to register 115,7 million shares for resale by selling stockholders, consisting of 115.4 million shares issuable upon conversion of Series B Preferred Stock at a reduced conversion price of $0.1210 and 288,432 shares underlying Series B Warrants. The filing is a mandatory registration under the Registration Rights Agreement, and the company will not receive proceeds except potentially ~$5.3 million if PCCU exercises its warrants for cash. The filing coincides with the imminent delisting of the company's securities from Nasdaq on November 18, 2026, a substantial going concern doubt, and a pending non-binding merger term sheet with Opifex that would dilute existing stockholders to ~15% ownership.
Key Financial Metrics
Key Facts
- Registers 115,705,691 shares for resale: 115,417,259 shares from Series B Preferred conversion at $0.1210 and 288,432 shares from Series B Warrants at $18.6336.
- Company will not receive proceeds from selling stockholders; potential ~$5.3 million gross proceeds only if PCCU exercises Series B Warrants for cash.
- Nasdaq determined to delist common stock and warrants; trading suspended at open of business on November 18, 2026.
- Series B Preferred conversion price reduced from $18.6336 to $0.1210 on October 22, 2026, causing substantial dilution; shares outstanding rose from ~1.0 million at Sept 30, 2026 to 148,760,916 as of Nov 11, 2026.
- Substantial doubt about ability to continue as a going concern; operating loss of $3.8 million and net cash used in operations of $4.0 million for nine months ended Sept 30, 2026.
- Non-binding term sheet with Opifex Media for a proposed transaction; Opifex holders would own ~85% of combined company, existing holders ~15%.
- Total revenue declined 49.7% in 2025 to $7.7 million from $15.2 million in 2024.
- Abaca litigation: range of reasonably possible loss $0 to $7.8 million; trial held August 10-11, 2026, ruling pending.
- Material weakness in internal control over financial reporting related to loan documentation and expected credit loss estimation remains outstanding.
- PCCU accounted for $5.4 million, or 93%, of total revenue for nine months ended Sept 30, 2026.
Financial Impact
Revenue declined 49.7% YoY in 2025 to $7.7 million. Nine-month 2026 revenue was $5.86 million, up 4.5% YoY. Net loss of $2.16 million in 2025. Cash of $4.4 million as of Sept 30, 2026. Potential warrant exercise proceeds of ~$5.3 million. Indemnification exposure theoretical maximum ~$33.8 million on $52.1 million loan portfolio.
Risk Factors
- Imminent delisting from Nasdaq on November 18, 2026 reduces liquidity and may impair ELOC draws.
- Substantial going concern doubt; recurring operating losses and negative cash flow from operations.
- Massive dilution from Series B Preferred conversions at $0.1210 and potential further anti-dilution adjustments.
- Unlimited indemnification obligation under Second Amended CAA with theoretical maximum exposure of ~$33.8 million.
- Adverse Abaca litigation outcome up to $7.8 million could exceed available cash.
- Proposed Opifex transaction may not complete and would substantially dilute existing stockholders.
- Material weakness in internal controls over financial reporting remains outstanding.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001493152-26-051855 |
| Exhibit: ex107.htm | 0001493152-26-051855 |
| Exhibit: ex5-1.htm | 0001493152-26-051855 |
| Exhibit: ex23-1.htm | 0001493152-26-051855 |
| Exhibit: ex23-2.htm | 0001493152-26-051855 |
| Document: 0001493152-26-051855-index-headers.html | 0001493152-26-051855 |
| Document: 0001493152-26-051855-index.html | 0001493152-26-051855 |
| Document: 0001493152-26-051855.txt | 0001493152-26-051855 |
Track record
27 reports on SHFS
13 of 16 bullish or bearish reports moved the stock their way by T+5. Best: +98.49% at T+60 after the Aug 11, 2026 report. 16 of 18 went positive at some point.
Filters
- Nov 13, 20263d ago S-1 Bearish 7/10 Viewing Entry $0.0277 Now $0.0230 +16.97% settles Nov 23
- Nov 13, 20263d ago DEFA14A Bearish 7/10 Entry $0.0280 Now $0.0230 +17.86% settles Nov 23
- Nov 12, 20264d ago 425 Bearish 7/10 Entry $0.0303 Now $0.0230 +24.09% settles Nov 20
- Nov 12, 20264d ago 8-K Bearish 9/10 Entry $0.0303 Now $0.0230 +24.09% settles Nov 20
- Nov 9, 20267d ago DEFA14A Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
- Nov 9, 20267d ago 425 Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
- Nov 9, 20267d ago 8-K Bearish 7/10 No price data
- Nov 9, 20267d ago Press Release Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
- Nov 9, 20267d ago Press Release Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
- Oct 30, 202617d ago 8-K Bearish 7/10 Entry $0.0462 to $0.0248 Now $0.0230 +50.22% ▲ +46.32% +46.40% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers